Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Atropine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.62 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.62 |
| ▸ | CHRM3 known ✓ | P20309 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.62 |
| ▸ | HTR2C | P28335 | 2/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.62 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.62 |
| ▸ | HRH1 | P35367 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.62 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Atropine SCHEMBL27893159 | 1.00 | MAPT (0.69) | MAPTALDH1A1CHRM2CHRM5CHRM1 | |
| Atropine SCHEMBL27778824 | 0.96 | MAPT (0.63) | MAPTALDH1A1CHRM2CHRM5CHRM1 | |
| Atropine SCHEMBL27893156 | 0.95 | MAPT (0.61) | MAPTALDH1A1CHRM2CHRM5CHRM1 | |
| Diphenoxylate SCHEMBL865011 | 0.86 | OPRM1 (0.64) | MAPTALDH1A1CHRM2CHRM5CHRM1 | |
| Diphenoxylate SCHEMBL16766515 | 0.85 | OPRM1 (0.65) | MAPTALDH1A1CHRM2CHRM5CHRM1 | |
| Atropine SCHEMBL11184482 | 0.84 | MAPT (0.98) | MAPTALDH1A1CHRM2CHRM5CHRM1 | |
| Hyoscyamine SCHEMBL34273 | 0.83 | MAPT (1.00) | MAPTALDH1A1CHRM2CHRM5CHRM1 | |
| Atropine SCHEMBL3050622 | 0.83 | MAPT (1.00) | MAPTALDH1A1CHRM2CHRM5CHRM1 | |
| Atropine SCHEMBL31132 | 0.83 | MAPT (1.00) | MAPTALDH1A1CHRM2CHRM5CHRM1 | |
| Atropine SCHEMBL1411666 | 0.83 | MAPT (1.00) | MAPTALDH1A1CHRM2CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107531690-A | The amines of 4,5,6,7 tetrahydrochysene 1H pyrazolos [4,3 c] pyridine 3 as CBP and/or EP300 inhibitor | 基因泰克公司 | 2018-01-02 | — | — | CN | disclosed |
| CN-107406429-A | Pyridazinone derivative and its purposes in treating cancer | 基因泰克公司 | 2017-11-28 | — | — | CN | disclosed |
| CN-107108512-A | Therapeutic compound and application thereof | 基因泰克公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-107074824-A | Phthalazine derivatives of formula (I) as PCAF and GCN5 inhibitors for the treatment of cancer | 基因泰克公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-107074823-A | Therapeutic compound and application thereof | 基因泰克公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-101808515-A | Octahydropentalene compounds as chemokine receptor antagonists | ABBOTT LAB | 2010-08-18 | — | — | CN | disclosed |
| CN-101652069-A | Novel imidazo-based heterocycles | ABBOTT LAB US | 2010-02-17 | — | — | CN | disclosed |
| CN-101553224-A | Novel imidazothiazoles and imidazoxazoles | ABBOTT LAB (US) | 2009-10-07 | — | — | CN | disclosed |